ProLynx announces publication and initiation of patient recruitment for a trial of once-monthly treatment of diabetes in cats
05. September 2019 09:00 ET
|
ProLynx LLC
SAN FRANCISCO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Today, ProLynx announced publication of data supporting therapy of Type 2 diabetes in cats with PLX039, a GLP-1 receptor agonist that can be...